Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Industries that range from pharmaceuticals to tech, and even fashion, have signaled they could build more capacity in the U.S ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

Dassault Systèmes is the world leader in mechanical computer-aided design software. Its high-end CAD software, Catia, is the industry standard in automotive, aerospace, and industrial products while ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Merck maintained its 2025 full-year revenue guidance of $64.1 billion to $65.6 billion, representing 1% to 3% growth excluding foreign exchange impacts. EPS guidance was adjusted to $8.82 to $8.97, ...

Major drugmakers were a standout on a tumultuous day of corporate earnings on Thursday, beating expectations even as they ...

U.S. pharmaceutical giant Merck has warned that existing tariffs imposed by the Trump administration will cost the company an ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Pelthos Therapeutics, a Durham-based wholly owned subsidiary of Ligand Pharmaceuticals (Nasdaq: LGND), is combining with ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...